🇺🇸 FDA
Patent

US 7521551

Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy

granted A61KA61K41/0057A61K41/0071

Quick answer

US patent 7521551 (Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy) held by Miravant Pharmaceuticals, Inc. expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Miravant Pharmaceuticals, Inc.
Grant date
Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K41/0057, A61K41/0071, A61P, A61P35/00